Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BLIS K12 in Hospitalized COVID-19 Patients
NCT05043376Completed
- Sponsor
- King Edward Medical University
- Start
- Sep 2021
- Primary completion
- Nov 2021
- Modality
- Yeast Strains, Defined Consortia, Bacterial Strains
- Countries
- 1
01
Overview
Randomised, open-label trial in coronavirus disease 2019 (COVID-19) comparing Standard of care with BLIS K12 (2 arms). Primary endpoint: Recovery and live discharge at 14 days. Started Sep 2021; status: completed.
02
Drugs
Streptococcus salivarius K12
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT05043376.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05043376.